CD82 and breast carcinoma: Conversely, a study by Zhong et al., (2016) observed that KAI-1 expression is attenuated more often in ER- and PR-negative cases than that of positive cases, which suggested the loss of KAI-1 is associated with poor prognosis in breast cancer (Zhong et al., 2016).